Axio Biosolutions expands operations to UK
Axiostat is an advanced wound management product that is being successfully used by Military and para-military forces and emergency services world-over.
AXIO BIOSOLUTIONS
-
Axio Biosolutions announces ESOP Buyback program for employees
Axio launched Employee Stock ownership plan in 2017 to make employees ESOP holders which resulted in over 40% of the team receiving ESOP grants. This ESOP buyback program is for half a million USD worth options.
-
Axio Biosolutions receives another FDA clearance for Axiostat Patch for Vascular Bleeding Control
-
Axio Biosolutions enters the veterinary segment with SureKlot
-
Axio Biosolutions receives European CE Mark approval for MaxioCel
-
Medtech firm Axio Biosolutions lands $5.2M funding led by Omidyar
-
Axio Biosolutions announces Scientific Advisory Board
-
We need healthcare technologies that are efficient and affordable: Leo Mavely
-
Axiostat becomes first wound dressing from India to get US FDA clearance
-
Axio raises $7.4m from Ratan Tata, others
Advertisement
More in AXIO BIOSOLUTIONS
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
